Botox vs. Baclofen for Upper Limb Spasticity

Status Terminated

Clinical Trial Summary

The purposes of this pilot study are to evaluate the safety and efficacy of Botox® compared to the safety and efficacy of oral baclofen in reducing muscle tone-related disability resulting from neurological damage or a stable neurological disorder and to evaluate drug-therapy tolerance.

Clinical Trial Description

Spasticity results from any injury to the central nervous system, including brain or spinal cord. Illnesses or injuries that typically cause spasticity include cerebral palsy, stroke, multiple sclerosis and traumatic brain or spinal cord injury. Common treatments for spasticity include physical and occupational therapy as well as oral medications such as baclofen, injected medications such as botulinum neurotoxin, intrathecal medications and surgical procedures. The approach to the treatment of spasticity is comprehensive in nature and these therapies have been widely applied to a broad population of patients including children, adults and older adults.

This is a single-center, randomized, prospective, parallel, double-blind study. Study duration is approximately 16 weeks.At Visit 2 (Baseline Visit), all eligible study subjects will be randomized to one of two treatment groups: intramuscular Botox plus oral placebo, or intramuscular placebo plus oral baclofen. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00280280
Study type	Interventional
Source	Vanderbilt University
Contact
Status	Terminated
Phase	Phase 1
Start date	February 2006
Completion date	February 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06150729` - Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
Completed	`NCT02400619` - Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT	Phase 1
Completed	`NCT02261142` - Efficacy and Cost-effectiveness of Spasticity Treatment With Multifocal TENS	N/A
Completed	`NCT01945684` - A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity	Phase 3
Completed	`NCT01444794` - Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
Terminated	`NCT02877836` - Functional MRI and DTI in the Preoperative Assessment of Dystonia	N/A
Completed	`NCT02334683` - Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia	N/A
Completed	`NCT02170779` - Developing and Testing a Comprehensive MS Spasticity Management Program	Phase 2
Recruiting	`NCT05674604` - Cryoneurolysis for Knee and Shoulder Pain in an Inpatient Setting
Not yet recruiting	`NCT05926596` - Leg Stretching Using an Exoskeleton on Demand for People With Spasticity	N/A
Terminated	`NCT01712087` - Long-term Surveillance of the MedStream Programmable Infusion System
Completed	`NCT03906305` - Dry Needling and Bobath Treatment Clinical Effects Focused on Stroke Patients	N/A
Completed	`NCT03302741` - Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings	Phase 4
Completed	`NCT02291159` - Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke	N/A
Completed	`NCT01743651` - Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis	Phase 3
Completed	`NCT01523210` - DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle	N/A
Completed	`NCT02073513` - Kinesiotaping the Hand in Cerebral Palsy	N/A
Completed	`NCT00607542` - Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity	Phase 1/Phase 2
Completed	`NCT00702468` - Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis	Phase 3
Active, not recruiting	`NCT04815967` - Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity	Phase 2/Phase 3